We report the patient who born to a mother addicted to heroin who suffered NAS and was successfully treated with fentanyl infusion as far as we know, is the first in the literature.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Neonatal abstinence syndrome (NAS) is a clinical condition in which infants born to mothers with substance addictions (heroin, cannabis, opiates, etc.) exhibit withdrawal symptoms and physical addiction as they have been exposed to the substances prenatally and are lacking the substance postnatally.
📊
Key Findings & Data:Most often emerges with the central nervous system and autonomous nervous system findings in NAS.
💡
Conclusion & Impact:We report the patient who born to a mother addicted to heroin who suffered NAS and was successfully treated with fentanyl infusion as far as we know, is the first in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Neonatal abstinence syndrome (NAS) is a clinical condition in which infants born to mothers with substance addictions (heroin, cannabis, opiates, etc.) exhibit withdrawal symptoms and physical addiction as they have been exposed to the substances prenatally and are lacking the substance postnatally. Most often emerges with the central nervous system and autonomous nervous system findings in NAS. Seizures have been reported rarely and require emergency treatment. We report the patient who born to a mother addicted to heroin who suffered NAS and was successfully treated with fentanyl infusion as far as we know, is the first in the literature.
🔖
Cite This Article
KIRIK, S., YURTTUTAN, S., BOZKAYA, A., SEĞMEN, B. (2022). The Treatment of Neonatal Abstinence Syndrome with Fentanyl in a Premature Infant. Haydarpaşa Numune Medical Journal, Cilt: 61 - Sayı: 4, 466–468. https://ajindex.com/articles/651401
Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, et al. Neonatal abstinence syndrome: Update on diagnostic and therapeutic strategies. Pharmacotherapy 2017;37:814–23
Regan J, Chambers F, Gorman W, MacSullivan R. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG. 2000;107:570–2
Kennare R, Heard A, Chan A. Substance use during pregnancy: Risk factors and obstetric and perinatal outcomes in South Australia. Aust N Z J Obstet Gynaecol 2005;45:220–5
Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol 2015;39:561–5
Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics 2012;129:540–60
Behnke M, Smith VC. Prenatal Substance Abuse: Shortand long-term effects on the exposed fetus. Pediatrics 2013;131:1009–24
Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006;117:1163–9
Lozano J, García-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit 2007;29:711–34